SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026362
Filing Date
2022-12-12
Accepted
2022-12-12 13:02:07
Documents
13
Period of Report
2022-12-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20221209.htm   iXBRL 8-K 62166
2 EX-3.1 rxst-ex3_1.htm EX-3.1 349771
  Complete submission text file 0000950170-22-026362.txt   573698

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxst-20221209.xsd EX-101.SCH 2454
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxst-20221209_pre.xml EX-101.PRE 10217
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxst-20221209_lab.xml EX-101.LAB 13895
7 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20221209_htm.xml XML 4867
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

IRS No.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 221456742
SIC: 3851 Ophthalmic Goods